Risk Prediction of Cardiovascular Disease in Type 2 Diabetes

被引:136
|
作者
Cederholm, Jan [1 ]
Eeg-Olofsson, Katarina [2 ]
Eliasson, Bjoern [2 ]
Zethelius, Bjoern [1 ]
Nilsson, Peter M. [3 ]
Gudbjornsdottir, Soffia [2 ]
机构
[1] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden
[2] Gothenburg Univ, Dept Med, Sahlgrenska Univ Hosp, Gothenburg, Sweden
[3] Lund Univ, Univ Hosp, Dept Clin Sci, Malmo, Sweden
关键词
D O I
10.2337/dc08-0662
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Risk prediction models obtained in samples from the general population do mot perform well in type 2 diabetic patients. Recently, 5-year risk estimates were proposed as being more accurate than 10-year risk estimates. This study presents a diabetes-specific equation for estimation of the absolute 5-year risk of first incident fatal/nonfatal cardiovascular disease (CVD) in type 2 diabetic patients with the use of A1C and clinical characteristics. RESEARCH DESIGN AND METHODS - The study was based on 11,646 female and male patients, aged 18-70 years, from the Swedish National Diabetes Register with 1,482 first incident CVD events based on 58,342 person-years with mean follow-up) of 5.64 years. RESULTS - This risk equation incorporates A1C, as in the UK Prospective Diabetes Study risk engine, and several clinical characteristics: onset age of diabetes, diabetes duration, sex, BMI, smoking, systolic blood pressure, and antihypertensive and lipid-reducing drugs. All predictors included were associated with the Outcome (P < 0.0001, except for BMI P = 0.0016) with Cox regression analysis. Calibration was excellent when assessed by comparing observed and predicted risk. Discrimination was sufficient, with a receiver operator curve statistic of 0.70. Mean 5-year risk of CVD in all patients was 12.0 +/- 7.5%, whereas 54% of the patients had a 5-year risk >= 10%. CONCLUSIONS - This more simplified risk equation enables 5-year risk prediction of CVD based on easily available nonlaboratory predictors in clinical practice and A1C and was elaborated in a large observational study obtained from the normal patient population aged up to 70 years.
引用
收藏
页码:2038 / 2043
页数:6
相关论文
共 50 条
  • [1] Cardiovascular disease risk prediction in type 1 diabetes
    Farran, B.
    McGurnaghan, S.
    Blackbourn, L.
    McKeigue, P. M.
    Colhoun, H. M.
    [J]. DIABETOLOGIA, 2017, 60 : S532 - S533
  • [2] Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease
    Herder, C.
    Karakas, M.
    Koenig, W.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (01) : 52 - 66
  • [3] Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review
    van Dieren, S.
    Beulens, J. W. J.
    Kengne, A. P.
    Peelen, L. M.
    Rutten, G. E. H. M.
    Woodward, M.
    van der Schouw, Y. T.
    Moons, K. G. M.
    [J]. HEART, 2012, 98 (05) : 360 - 369
  • [4] Type 2 diabetes and cardiovascular disease: Reducing the risk
    Bartels, David W.
    Davidson, Michael H.
    Gong, William C.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (02): : S2 - S15
  • [5] Cardiovascular disease risk stratification in type 2 diabetes
    Esdaile, Harriet
    Mayet, Jamil
    Hill, Neil
    [J]. DIABETIC MEDICINE, 2022, 39 (10)
  • [6] Cardiovascular risk prediction model for Omanis with type 2 diabetes
    Alrawahi, Abdul Hakeem
    Lee, Patricia
    Al-Anqoudi, Zaher A. M.
    Alrabaani, Muna
    Al-Busaidi, Ahmed
    Almahrouqi, Faisal
    Albusaidi, Ahmed M.
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (02) : 105 - 110
  • [7] Risk prediction of cardiovascular disease in type 2 diabetes - a new risk equation from the Swedish NDR
    Zethelius, B.
    Gudbjornsdottir, S.
    Eliasson, B.
    Eeg-Olofsson, K.
    Svensson, A. -M.
    Cederholm, J.
    [J]. DIABETOLOGIA, 2010, 53 : S68 - S68
  • [8] Cardiovascular disease risk prediction in type 1 diabetes: Accounting for the differences
    Ruppert, Kristine
    Roberts, Mark S.
    Orchard, Trevor J.
    Zgibor, Janice C.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 78 (02) : 234 - 237
  • [9] Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes
    Looker, Helen C.
    Colombo, Marco
    Agakov, Felix
    Zeller, Tanja
    Groop, Leif
    Thorand, Barbara
    Palmer, Colin N.
    Hamsten, Anders
    de Faire, Ulf
    Nogoceke, Everson
    Livingstone, Shona J.
    Salomaa, Veikko
    Leander, Karin
    Barbarini, Nicola
    Bellazzi, Riccardo
    van Zuydam, Natalie
    McKeigue, Paul M.
    Colhoun, Helen M.
    [J]. DIABETOLOGIA, 2015, 58 (06) : 1363 - 1371
  • [10] Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes
    Helen C. Looker
    Marco Colombo
    Felix Agakov
    Tanja Zeller
    Leif Groop
    Barbara Thorand
    Colin N. Palmer
    Anders Hamsten
    Ulf de Faire
    Everson Nogoceke
    Shona J. Livingstone
    Veikko Salomaa
    Karin Leander
    Nicola Barbarini
    Riccardo Bellazzi
    Natalie van Zuydam
    Paul M. McKeigue
    Helen M. Colhoun
    [J]. Diabetologia, 2015, 58 : 1363 - 1371